Oral Oncology
Volume 46, Issue 6 , Pages 418-422 , June 2010

Diagnostic clinical aids in oral cancer

  • Juan Seoane Lestón
  • ,
  • Pedro Diz Dios

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: School of Medicine and Dentistry, Santiago de Compostela University, c/Entrerríos sn, 15782 Santiago de Compostela (A Coruña), Spain. Fax: +34 981 562226.

References 

  1. Trullenque-Eriksson A, Muñoz-Corcuera M, Campo-Trapero J, Cano-Sanchez J, Bascones-Martinez A. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal. 2009;14:E210–E216
  2. Epstein JB, Sciubba J, Silverman S, Sroussi HY. Utility of toluidine blue in oral premalignant lesion and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck. 2007;29:948–958
  3. Epstein JB, Silverman S, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008;44:538–544
  4. Epstein JB, Güneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg. 2009;17:79–87
  5. Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol. 1989;67:621–627
  6. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10–22
  7. Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescence illumination (ViziLite) in the visualisation of oral mucosa White lesions. Oral Oncol. 2007;43:820–824
  8. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg. 2007;65:424–426
  9. Bhalang K, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L, Swasdison S. The application of acetic acid in the detection of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pahol Oral Radiol Endod. 2008;106:371–376
  10. McIntosh L, McCullough MJ, Farah CS. The assessment of diffused light illumination and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions. Oral Oncol. 2009;45:E227–E231
  11. Huber MA. Assessment of the VELscope as an adjunctive examination tool. Tex Dent. 2009;126:528–535
  12. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009;I:5
  13. De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol. 2005;41:117–131
  14. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Reboiras-Lopez MD, Gandara-Vila P, Gándara-Rey JM, et al. Exfoliative cytology for diagnosing oral cancer. Biotech Histochem. 2009;25:1–11
  15. Freitas MD, Garcia AG, Abelleira AC, Carneiro JLM, Rey JMG. Aplicaciones de la citología exfoliativa en el diagnóstico del cáncer oral. Med Oral Patol Oral Cir Bucal. 2004;9:355–361
  16. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. US Collaborative OralCDx Study Group. J Am Dent Assoc. 1999;130:1445–1457
  17. Bhoopathi V, Kabani S, Mascarenhas AK. Low positive predictive value of the oral brush biopsy in detecting dysplastic oral lesions. Cancer. 2009;115:1036–1040
  18. Hohlweg-Majert B, Deppe H, Metzger MC, Schumm S, Hoefler H, Kesting MR, et al. Sensitivity and specificity of oral brush biopsy. Cancer Invest. 2009;27:293–297
  19. Poate TW, Buchanan JA, Hodgson TA, Speight PM, Barret AW, Moles DR, et al. An audit of the efficacy of the oral brush biopsy technique in a specialist oral medicine unit. Oral Oncol. 2004;40:829–834
  20. Acha A, Ruesga MT, Rodriguez MJ, Martinez Pancorbo MA, Aguirre JM. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal. 2005;10:95–102
  21. Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer. 2006;5:11
  22. Spivavack SD, Hurteau GJ, Jain R, Kumar SV, Aldous KM, Gierthy JF, et al. Gene–environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res. 2004;64:6805–6813
  23. Larsen SR, Johansen J, Sorensen JA, Krogdahl A. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med. 2009;38:657–662
  24. Seoane J, Varela-Centelles P, Ramirez JR, Romero MA, De La Cruz A. Artefacts produced by suture traction during incisional biopsy of oral lesions. Clin Otolaryngol. 2002;27:549–553
  25. Moule L, Parsons PA, Irvine GH. Avoiding artefacts in oral biopsies: the punch biopsy versus the incisional biopsy. Br J Maxillofac Surg. 1995;33:244–247
  26. Pogrel MA, McCraken KJ, Daniels TE. Histologic evaluation of width of soft tissue necrosis adjacent to carbon dioxide incisions. Oral Surg Oral Med Oral Pathol. 1990;70:564–568
  27. Horch HH, Gerlach KL, Schaefer HE. CO2 laser surgery of oral premalignant lesions. Int J Oral Maxillofac Surg. 1986;15:19–24
  28. Kusukawa J, Suefuji Y, Ryu F, Noguchi R, Iwamoto O, Kameyama T. Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. J Oral Pathol Med. 2000;29:303–307
  29. Dyavanagoudar S, Kale A, Bhat K, Hallikerimath S. Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamous cell carcinoma. Indian J Dent Res. 2008;19:315–319
  30. Kusukawa J, Suefuji Y, Ryu F, Noguchi R, Iwamoto O, Kameyama T. Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. J Oral Pathol Med. 2000;29:303–307
  31. Klein DR. The use of the carbon dioxide laser in plastic surgery. South Med J. 1977;70:429–431
  32. Lee JJ, Hung HCh, Cheng SJ, Chiang ChP, Liu By, Yu ChH, et al. Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:217–225
  33. Woolgar JA, Triantafyllou A. Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol. 2009;45:361–385
  34. Bryne M, Koppang H, Lilleng R, Kjaerhheim A. Malignancy trading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166:375–381
  35. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med. 1995;24:198–200
  36. Khana SS, Karjodkar FR. Circulating immune complexes and trace elements (copper, iron and selenium) as markers in oral precancer and cancer: a randomised, controlled clinical trial. Head Face Med 2006;2:33 http://www.head-face-med.com/content/2/1/33 [accessed February 2010].
  37. Nagler RM, Barak M, Ben-Aryeh H, Peled M, Filatov M, Lauffer D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer. 1999;35:118–125
  38. Faria PCB, Servino-Sena AA, Nascimento R, Carvalho WJ, Loyola AM, Silva SJ, et al. Expression of annexin A1 in peripheral blood from oral squamous cell carcinoma patients. Oral Oncol. 2010;46:25–30
  39. Shpitzer T, Bahar G, Feeinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007;133:613–617
  40. Nagler RM, Lischinsky S, Diamond E, Klein E, Reznick AZ. New insights into salivary lactate dehydrogenase of human subjects. J Lab Clin Med. 2001;137:363–369
  41. Sanjay PR, Hallikeri K, Shivashankara AR. Evaluation of salivary sialic acid, total protein, and total sugar in oral cancer: a preliminary report. Indian J Dent Res. 2008;19:288–291
  42. Nagler RM. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol. 2009;45:1006–1010
  43. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15:5473–5477
  44. Closman JJ, Schimidt BL. The use of cone beam computed tomography as an aid in evaluating and treatment planning for mandibular cancer. J Oral Maxillofac Surg. 2007;65:766–771
  45. Wilder-Smith P, Lee K, Guo S, Zhang J, Osann K, Chen Z, et al. In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients. Lasers Surg Med. 2009;41:353–357

PII: S1368-8375(10)00095-3

doi: 10.1016/j.oraloncology.2010.03.006

Oral Oncology
Volume 46, Issue 6 , Pages 418-422 , June 2010